OLMA
Olema Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.75
+0.19%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-47.5%
Return on equity
-42.0%
Return on assets
-51.3%
Return on invested capital
0.00x
Asset turnover
-$164.7M
Cash from operations
$5.27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026